Advanced Biomed (ADVB) Depreciation & Amortization (CF) (2023 - 2026)

Advanced Biomed has disclosed Depreciation & Amortization (CF) across 4 years of filings, most recently posting $9326.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $9326.0, down 58.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $320326.0 (up 44.37% YoY), and the FY2025 annual result was $343830.0, down 13.96% from the prior year.
• Depreciation & Amortization (CF) came in at $9326.0 for Q1 2026 at Advanced Biomed, up from -$12857.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $275865.0 in Q2 2025 to a low of -$56760.0 in Q4 2024.
• The 4-year median for Depreciation & Amortization (CF) is $52945.5 (2023), against an average of $68311.7.
• Across the five-year window, Depreciation & Amortization (CF) tumbled 198.03% in 2024 and surged 79.24% in 2025, its largest moves.
• Advanced Biomed's Depreciation & Amortization (CF) stood at $57899.0 in 2023, then sank by 198.03% to -$56760.0 in 2024, then soared by 77.35% to -$12857.0 in 2025, then soared by 172.54% to $9326.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $9326.0 (Q1 2026), -$12857.0 (Q4 2025), and $47992.0 (Q3 2025), per Business Quant data.